|

|
 
Instructions to Authors
Articles for Trends in Endocrinology and Metabolism are usually commissioned
by the Editor-in-Chief, but proposals for articles are also considered.
Prospective authors should send a brief summary, citing key references,
to the Editor-in-Chief at the address detailed below. Guidelines will then
be provided for manuscript preparation if the proposal is accepted. The
submission of completed manuscripts without prior consultation with the
Editor-in-Chief is strongly discouraged. Authors should note that all major
articles in Trends in Endocrinology and Metabolism are peer reviewed and
publication cannot be guaranteed.
Reviews and Opinion articles form the foundation of each monthly issue.
Reviews are invited from leading researchers in a specific field and objectively
chronicle recent and important developments. Opinion articles provide
a forum for debate and hypothesis.
Trends in Endocrinology and Metabolism welcomes correspondence.
The decision to publish rests with the Editor-in-Chief, and the author(s)
of any article discussed in a Letter will normally be invited to reply.
Letters can address topics raised in recent issues of the journal, or
other matters of general interest to endocrinologists. Letters should
be no more than 600 words long with a maximum of 10 references and one
figure. An electronic version of the text should be e-mailed to tem@elsevier.com
 
Advisory Editorial Board
D. Accili, New York, NY, USA
A.L. Barkan, Ann Arbor, MI, USA
H.G. Burger Clayton, VIC, Australia
W.W. Chin, Indianapolis, IN, USA
G. Chrousos, Bethesda, MD, USA
E. Clauser, Paris, France
R.N. Clayton, Stoke-on-Trent, UK
M.L. Dufau, Bethesda, MD, USA
G. Emons, Gottingen, Germany
J.W. Funder, Melbourne, VIC, Australia
J.A. Garcia Sainz, Mexico D.F., Mexico
M.B. Grumbach, San Francisco, CA, USA
M.A. Lazar, Philadelphia, PA, USA
T.J. Martin, Melbourne, VIC, Australia
D.P McDonnell, Durham, NC, USA
F. Mendelsohn, Melbourne, VIC, Australia
C.R. Mendelson, Dallas, TX, USA
L.A. Meserve, Ohio, USA
Z. Naor, Tel Aviv, Israel
M.I. New, New York, NY, USA
R. Pestell, Philadelphia, PA, USA
W.K Samson, St. Louis, MO, USA
P.M. Stewart, Birmingham, UK
J.F. Strauss, Philadelphia, PA, USA
G. Tsujimoto, Tokyo, Japan
J.D. Wilson, Dallas, TX, USA
 
Abstracting/Indexing
Chemical Abstracts
Current Contents (Life Science)
Medline/MEDLARS Online
Reference Update
Science Citation Index
SciSearch/Science Citation Index Expanded
 
Bibliographic Information
Commenced publication 1990
Volume 19
2008, 10 issues
ISSN: 1043-2760
 
Statement on publishing ethics
The
Editor(s) and Publisher of this Journal believe that there are fundamental
principles underlying scholarly or professional publishing. While this
may not amount to a formal 'code of conduct', these fundamental principles
with respect to the authors' paper are that the paper should: i) be the
authors' own original work, which has not been previously published elsewhere,
ii) reflect the authors' own research and analysis and do so in a truthful
and complete manner, iii) properly credit the meaningful contributions
of co-authors and co-researchers, iv) not be submitted to more than one
journal for consideration, and v) be appropriately placed in the context
of prior and existing research. Of equal importance are ethical guidelines
dealing with research methods and research funding, including issues dealing
with informed consent, research subject privacy rights, conflicts of interest,
and sources of funding. While it may not be possible to draft a 'code'
that applies adequately to all instances and circumstances, we believe
it useful to outline our expectations of authors and procedures that the
Journal will employ in the event of questions concerning author conduct.
 
Conflict of Interest Policy
The
Publisher now requires authors to declare any conflicts of interest that relate
to papers accepted for publication in this Journal. A conflict of interest may
exist when an author or the author's institution has a financial or other
relationship with other people or organizations that may inappropriately
influence the author’s work. A conflict can be actual or potential and full
disclosure to the Journal is the safest course. All submissions to the Journal
must include disclosure of all relationships that could be viewed as presenting
a potential conflict of interest. The Journal may use such information as a
basis for editorial decisions and may publish such disclosures if they are
believed to be important to readers in judging the manuscript. A decision may be
made by the Journal not to publish on the basis of the declared conflict. For
more information, please refer to:
http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest
 
Copyright statement
© 2008 Elsevier, Ltd. All rights reserved.
This journal and the individual contributions contained in it are protected
under copyright by Elsevier Ltd, and the following terms and conditions
apply to their use:
 
Photocopying
Single photocopies of single articles may be made for personal use as
allowed by national copyright laws. Permission of the publisher and payment
of a fee is required for all other photocopying, including multiple or
systematic copying, copying for advertising or promotional purposes, resale,
and all forms of document delivery. Special rates are available for educational
institutions that wish to make photocopies for non-profit educational
classroom use.
Elsevier Science Rights & Permissions Department
PO Box 800
Oxford
UK OX5 1DX
Tel:+44 (0) 1865 843830
Fax: +44 (0) 1865 853333
E-mail: permissions@elsevier.co.uk
|
|
You may also contact Global Rights directly through Elsevier's home page (http://www.elsevier.com), selecting first 'Customer Support', then 'Permissions', then 'Permissions Request Form'.
In the USA, users
may clear permissions and make payments through the
Copyright Clearance Center Inc
222 Rosewood Drive
Danvers
MA 01923, USA
Tel: +1 (978) 750 8400
Fax: +1 (978) 750 4744
and in the UK through
the
Copyright Licensing
Agency Rapid Clearance Service (CLARCS)
90 Tottenham Court Road
London, UK W1P 0LP
Tel: +44 (0)
20 7631 5555
Fax: +44 (0)
20 7436 5500
Other countries may
have a local reprographic rights agency for payments.
 
Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles
including abstracts for internal circulation within their institutions.
Permission of the publisher is required for resale or distribution outside
the institution.
Permission of the publisher is required for all other derivative works,
including compilations and translations.
 
Electronic Storage or Usage
Permission of the publisher is required to store or use electronically
any material contained in this journal, including any article or part
of an article. Contact the publisher at the address indicated. Except
as outlined above, no part of this publication may be reproduced, stored
in a retrieval system or transmitted in any form or by any means, electronic,
mechanical, photocopying, recording or otherwise, without prior written
permission of the publisher. Address permissions requests to: Elsevier
Science Rights & Permissions Department, at the mail, fax and e-mail addresses
noted above.
 
Notice
No responsibility is assumed by the Publisher for any injury and/or damage
to persons or property as a matter of products liability, negligence or
otherwise, or from any use or operation of any methods, products, instructions
or ideas contained in the material herein. Because of rapid advances in
the medical sciences, in particular, independent verification of diagnoses
and drug dosages should be made.
Although all advertising material is expected to conform to ethical (medical)
standards, inclusion in this publication does not constitute a guarantee
or endorsement of the quality or value of such product or of the claims
made of it by its manufacturer.
|